The Lancet Neurology in conversation with
En podkast av The Lancet Group - Torsdager
187 Episoder
-
Giuseppe Citerio on frailty and TBI
Publisert: 19.1.2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Publisert: 20.12.2021 -
Olivier Rascol on amantadine for patients with movement disorders
Publisert: 17.11.2021 -
Antonio Uccelli on stems cells for MS
Publisert: 20.10.2021 -
Priya Palta on blood pressure control and cognitive decline
Publisert: 15.9.2021 -
Adam Boxer on tau biomarkers
Publisert: 18.8.2021 -
Irene Cortese on the difficulties of designing clinical trials
Publisert: 21.7.2021 -
Doug Turnbull on mitochondrial diseases in adults
Publisert: 16.6.2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Publisert: 19.5.2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Publisert: 21.4.2021 -
Anne MacGregor on menstrual migraine
Publisert: 17.3.2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Publisert: 17.2.2021 -
Spinal cord injury and degenerative cervical myelopathy
Publisert: 20.1.2021 -
Genetic risk factors for sCJD
Publisert: 22.12.2020 -
Prednisone in short-term prevention of cluster headache
Publisert: 24.11.2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Publisert: 21.10.2020 -
Neurological associations of COVID-19
Publisert: 4.9.2020 -
Advances in understanding of Rett syndrome
Publisert: 31.7.2020 -
Management of Parkinson's disease
Publisert: 17.6.2020 -
Optimal time to treat Huntington's Disease
Publisert: 26.5.2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
